Table 5.
Predictors of the lethal outcome in the group of patients coinfected with CDI and COVID-19.
| Risk Factors | p | Odds Ratio | 95% C.I. for Odds Ratio | |
|---|---|---|---|---|
| Lower | Upper | |||
| Age | 0.000 | 1.273 | 1.194 | 1.356 |
| Charlson comorbidity score | 0.019 | 1.352 | 1.051 | 1.739 |
| Proton pump inhibitors | 0.620 | 1.284 | 0.478 | 3.449 |
| Corticosteroids | 0.252 | 1.806 | 0.657 | 4.962 |
| Chemotherapy | 0.080 | 0.413 | 0.153 | 1.112 |
| WBC above 15 × 109/L | 0.732 | 0.843 | 0.317 | 2.242 |
| Albumin ≤ 25 g/L | 0.399 | 1.496 | 0.587 | 3.814 |
| Creatinine > 200 mmol/L | 0.131 | 1.702 | 0.853 | 3.396 |
| CRP | 0.015 | 1.011 | 1.002 | 1.020 |
| Cephalosporin of the third generation | 0.930 | 0.959 | 0.379 | 2.431 |
| Fluoroquinolone | 0.288 | 0.620 | 0.257 | 1.497 |
| Amoxicillin–clavulanic acid | 0.799 | 0.830 | 0.198 | 3.485 |
CDI: Clostridium difficile infection; COVID-19: Coronavirus disease 2019 (infection with the SARS-CoV-2 virus); C.I.: confidence interval CRP: C-reactive protein; WBC—white blood cells.